報價延遲最少15分鐘:2025/01/21 19:21 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.52 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.49/-1.58
|
|
企業價值
234.28M
|
| 資產負債 |
|
每股賬面淨值
4.86
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
0.15
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 19:21 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides. |